In Philadelphia this week, a strategic roadmap will be published to aid in the fight against Alzheimer’s Disease. The University of Pennsylvania Health System claims the roadmap will “link the latest scientific findings with clinical care and bring together patients, families, scientists, pharmaceutical companies, regulatory agencies, and advocacy organizations behind a common set of prioritized goals.”
News Medical reports that, right now, 5.4 million people are living with Alzheimer’s disease. It is the sixth leading cause of death in the United States, and the only one of the top 10 causes that cannot at this time be prevented, cured, or even significantly slowed in any way.
The roadmap will be published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association and is the outcome of a meeting held in June among Alzheimer’s researchers, advocates, and clinicians.
“Our plan aims to provide good quality care for affected patients and families, advance our understanding of the pathophysiology and natural history of AD and other dementias, develop effective treatments to slow or prevent these diseases, and translate scientific advances successfully into policy and practice,” the authors wrote.
If all of the roadmap’s recommendations are adopted by governments, researches, and others involved, the authors of the plan hope that effective treatments for Alzheimer’s and other types of dementia can be developed within a decade.
Alzheimer’s disease is a fatal, degenerative condition and is the most common form of dementia. Patients experience gradual to severe loss of memory and other functions. According to the Alzheimer’s Association, one in eight older American’s suffers from Alzheimer’s Disease.